Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics, Policy & Law

Woodcock steps away from CDER for Operation Warp Speed; Marks back to CBER

Leadership shuffle at FDA to support government and company programs against COVID-19

Steve Usdin, Washington Editor
May 22, 2020 6:29 PM UTC

In a major reorganization intended to better align FDA’s activities with the national effort to develop COVID-19 countermeasures, Janet Woodcock is temporarily stepping away from her position as director of FDA’s Center for Drug Evaluation and Research, and Peter Marks is stepping away from his role as lead of vaccines at Operation Warp Speed.

Woodcock will be detailed to FDA’s Office of the Commissioner. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

U.S. Food and Drug Administration (FDA)